Page last updated: 2024-08-24

milnacipran and Depressive Disorder

milnacipran has been researched along with Depressive Disorder in 50 studies

Research

Studies (50)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (4.00)	18.7374
1990's	13 (26.00)	18.2507
2000's	28 (56.00)	29.6817
2010's	7 (14.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ameri, AA	1
Hozumi, S; Sekine, A; Shimizu, T	1
Antokhin, EY; Drobizhev, MY; Fedotova, AV; Kikta, SV	1
Horii, A; Imai, T; Inohara, H; Kitahara, T; Morita, Y; Takahashi, K; Uno, A	1
Dudka, J; Poleszak, E; Serefko, A; Stasiuk, W; Świąder, K; Szopa, A; Wlaź, P; Wyska, E	1
Hayashi, H; Sukma, M; Tanaka, K; Tohda, M	1
Dorozhenok, IIu; Terent'eva, MA; Voronova, EI	1
Bantsiele, GB; Bentué-Ferrer, D; Bourin, M; Laviolle, B; Reymann, JM; Saïkali, S	1
Akpinar, A	1
Clauw, DJ; Geisser, ME; Gendreau, MR; Palmer, R; Strand, V; Williams, DA	1
Aguglia, E; Amore, M; Delgado, PL; Gastpar, M; Hawley, C; Hirschfeld, RM; Kasper, S; Linden, M; Massana, J; Mendlewicz, J; Möller, HJ; Montgomery, SA; Nemeroff, CB; Saiz, J; Such, P; Torta, R; Versiani, M	1
Deprez, D; Panconi, E; Puozzo, C	1
Tajima, O	1
Bisserbe, JC	1
Arai, M	1
Briley, M	1
Isaac, MB; Isaac, MT	1
Gallo, F; Isaac, MB; Isaac, MT; Tournoux, A	1
Nakamura, J; Okamoto, K; Shinkai, K; Ueda, N; Yoshimura, R	1
Kunugi, H; Nakanishi, S; Takahashi, T	1
Faivre, T; Lemoine, P	1
Higuchi, H; Inoue, K; Ito, K; Itoh, K; Kamata, M; Naito, S; Nemeroff, CB; Sato, K; Shimizu, T; Suzuki, T; Takahashi, H; Yoshida, K	1
Cabanac, F; Panconi, E; Pezous, N; Sechter, D; Tournoux, A; Vandel, P; Weiller, E	1
Higuchi, H; Shimizu, T; Takahashi, H; Yoshida, K	1
Higuchi, H; Kamata, M	1
Kito, S; Koga, Y; Nakajima, T	1
Asada, T; Ohta, H; Sato, S; Terashima, Y; Yamakawa, Y	1
Hori, H; Mitoma, M; Nakamura, J; Okamoto, T; Sugita, A; Ueda, N; Umene, W; Yoshimura, R	1
Dubarek, W; Kucia, K	1
Ansseau, M; Bartholomé, F; Bataille, M; Charles, G; Darimont, P; De Wilde, J; Devoitille, JM; Papart, P; Schittecatte, M; Troisfontaines, B	1
Lecrubier, Y; Magne, V; Pletan, Y; Solles, A; Tournoux, A	1
Guelfi, JD; Lopez-Ibor, J; Pletan, Y; Prost, JF; Tournoux, A	1
Kasper, S; Pletan, Y; Solles, A; Tournoux, A	1
Briley, M; Montgomery, SA; Prost, JF; Solles, A	1
Briley, M; Montgomery, SA; Prost, JF; Puech, A; Solles, A	1
Koponen, H; Leinonen, E; Lepola, U; Mehtonen, OP; Rimon, R	1
Den Boer, JA; Steen, A	1
Ansseau, M; Corruble, E; Guelfi, JD; Plétan, Y; Samuelian, JC; Tonelli, I; Tournoux, A	1
Spencer, CM; Wilde, MI	1
Kelly, JP; Leonard, BE; Redmond, AM	1
Berdeaux, G; Bisserbe, JC; Chwalow, J; Mesbah, M; Rouillon, F; Smadja, C; Warner, B	1
Bisserbe, JC; Pezous, N; Rouillon, F; Warner, B	1
Fukuchi, T; Kanemoto, K	1
Endo, S; Imai, R; Isayama, K; Kanetani, K; Kimura, M; Suzuki, H	1
Bymaster, FP; Wong, DT	1
Ansseau, M; Botte, L; Darimont, P; De Nayer, A; De Wilde, J; Devoitille, JM; Evrard, JL; Gérard, MA; Mertens, C; von Frenckell, R	1
Ansseau, M; Serre, C; Sutet, P; von Frenckell, R	1
Ansseau, M; Botte, L; Darimont, P; De Nayer, A; de Wilde, J; Dejaiffe, G; Devoitille, JM; Evrard, JL; Mertens, C; von Frenckell, R	1
Demarez, JP; Huck, JC; Macher, JP; Serre, C; Sichel, JP; Von Frenckell, R	1

Reviews

14 review(s) available for milnacipran and Depressive Disorder

Article	Year
[Between depression and fibroniyalgia: the fate of the antidepressant]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2016, Volume: 116, Issue:4 Topics: Antidepressive Agents; Cyclopropanes; Depressive Disorder; Fatigue; Fibromyalgia; Humans; Milnacipran; Pain; Russia; Serotonin and Noradrenaline Reuptake Inhibitors	2016
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9 Topics: Antidepressive Agents; Congresses as Topic; Cyclopropanes; Decision Trees; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Lithium; Mianserin; Milnacipran; Mirtazapine; Morpholines; Practice Patterns, Physicians'; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2002
Pharmacology and pharmacokinetics of milnacipran. International clinical psychopharmacology, 2002, Volume: 17 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cyclopropanes; Depressive Disorder; Humans; Milnacipran; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors	2002
Japanese experience with dual-action antidepressants. International clinical psychopharmacology, 2002, Volume: 17 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Clinical Trials, Phase IV as Topic; Cyclopropanes; Depressive Disorder; Humans; Japan; Milnacipran; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2002
Clinical utility of milnacipran in comparison with other antidepressants. International clinical psychopharmacology, 2002, Volume: 17 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclopropanes; Depressive Disorder; Milnacipran	2002
New hope in the treatment of painful symptoms in depression. Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:1 Topics: Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride	2003
[Applications and safety of modern antidepressants in patients with liver diseases]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2007, Volume: 60, Issue:1-2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	2007
Clinical efficacy of milnacipran: placebo-controlled trials. International clinical psychopharmacology, 1996, Volume: 11 Suppl 4 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Controlled Clinical Trials as Topic; Cyclopropanes; Depressive Disorder; Double-Blind Method; Humans; Meta-Analysis as Topic; Milnacipran; Multicenter Studies as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1996
Milnacipran and selective serotonin reuptake inhibitors in major depression. International clinical psychopharmacology, 1996, Volume: 11 Suppl 4 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Depressive Disorder; Headache; Humans; Milnacipran; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1996
Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results. International clinical psychopharmacology, 1996, Volume: 11 Suppl 4 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclopropanes; Depressive Disorder; Double-Blind Method; Gastrointestinal Diseases; Humans; Milnacipran; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	1996
Efficacy and tolerability of milnacipran: an overview. International clinical psychopharmacology, 1996, Volume: 11 Suppl 4 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclopropanes; Depressive Disorder; Headache; Humans; Milnacipran; Selective Serotonin Reuptake Inhibitors	1996
Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. International clinical psychopharmacology, 1997, Volume: 12, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Cyclopropanes; Depressive Disorder; Female; Humans; Male; Milnacipran; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1997
Milnacipran. A review of its use in depression. Drugs, 1998, Volume: 56, Issue:3 Topics: Animals; Antidepressive Agents, Second-Generation; Cyclopropanes; Depressive Disorder; Humans; Milnacipran	1998
Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype? Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 2002, Volume: 58 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Cyclopropanes; Depressive Disorder; Duloxetine Hydrochloride; Humans; Milnacipran; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes	2002

Trials

18 trial(s) available for milnacipran and Depressive Disorder

Article	Year
Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain, 2010, Volume: 149, Issue:2 Topics: Activities of Daily Living; Adult; Cognition Disorders; Cyclopropanes; Depressive Disorder; Drug Resistance; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Outcome Assessment, Health Care; Pain Measurement; Patient Satisfaction; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Treatment Outcome	2010
Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects. Human psychopharmacology, 2003, Volume: 18, Issue:7 Topics: Adrenergic Agents; Adrenocorticotropic Hormone; Adult; Age Factors; Cyclopropanes; Depressive Disorder; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Milnacipran; Pindolol; Prolactin; Psychiatric Status Rating Scales; Regression Analysis; Serotonin Agents; Time Factors; Treatment Outcome	2003
Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency. Human psychopharmacology, 2003, Volume: 18, Issue:8 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Milnacipran; Pindolol; Psychiatric Status Rating Scales	2003
Subjective and polysomnographic effects of milnacipran on sleep in depressed patients. Human psychopharmacology, 2004, Volume: 19, Issue:5 Topics: Adolescent; Adult; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Electrocardiography; Female; Humans; Male; Middle Aged; Milnacipran; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Stages; Surveys and Questionnaires	2004
Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine. Human psychopharmacology, 2004, Volume: 19, Issue:8 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Milnacipran; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome	2004
Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study. Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cognition Disorders; Cyclopropanes; Depressive Disorder; Depressive Disorder, Major; Female; Functional Laterality; Humans; Male; Middle Aged; Milnacipran; Mood Disorders; Psychiatric Status Rating Scales; Stroke; Tomography, X-Ray Computed	2006
Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jun-30, Volume: 31, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Cyclopropanes; Depressive Disorder; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2007
Controlled comparison of milnacipran and fluoxetine in major depression. Psychopharmacology, 1994, Volume: 114, Issue:1 Topics: Adult; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Lorazepam; Male; Middle Aged; Milnacipran; Patient Dropouts; Psychiatric Status Rating Scales	1994
Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression. Acta psychiatrica Scandinavica, 1997, Volume: 96, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Clomipramine; Cyclopropanes; Depressive Disorder; Double-Blind Method; Female; Humans; Hypotension, Orthostatic; Male; Milnacipran; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome; Xerostomia	1997
A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder. International clinical psychopharmacology, 1997, Volume: 12, Issue:5 Topics: Adult; Aged; Antidepressive Agents; Clomipramine; Constipation; Cyclopropanes; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Milnacipran; Selective Serotonin Reuptake Inhibitors	1997
A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients. International clinical psychopharmacology, 1998, Volume: 13, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Milnacipran; Personality Inventory; Treatment Outcome	1998
Prevention of recurrent depressive episodes with milnacipran: consequences on quality of life. Journal of affective disorders, 2000, Volume: 58, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Female; Humans; Male; Middle Aged; Milnacipran; Quality of Life; Recurrence; Treatment Outcome	2000
Milnacipran efficacy in the prevention of recurrent depression: a 12-month placebo-controlled study. Milnacipran recurrence prevention study group. International clinical psychopharmacology, 2000, Volume: 15, Issue:3 Topics: Adult; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Disease Progression; Female; Humans; Male; Middle Aged; Milnacipran; Recurrence; Treatment Outcome	2000
Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. International clinical psychopharmacology, 2002, Volume: 17, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Cyclopropanes; Depressive Disorder; Female; Humans; Male; Middle Aged; Milnacipran; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stroke; Treatment Outcome	2002
Interest of a loading dose of milnacipran in endogenous depressive inpatients. Comparison with the standard regimen and with fluvoxamine. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1991, Volume: 1, Issue:2 Topics: Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Pulse	1991
Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studies. International clinical psychopharmacology, 1990, Volume: 5, Issue:1 Topics: Amitriptyline; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Dose-Response Relationship, Drug; Hospitalization; Humans; Milnacipran; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic	1990
Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients. Psychopharmacology, 1989, Volume: 98, Issue:2 Topics: Adult; Aged; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Clinical Trials as Topic; Cyclopropanes; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Random Allocation	1989
Double-blind placebo-controlled study of milnacipran in hospitalized patients with major depressive disorders. Neuropsychobiology, 1989, Volume: 22, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Milnacipran; Personality Tests; Randomized Controlled Trials as Topic; Single-Blind Method	1989

Other Studies

18 other study(ies) available for milnacipran and Depressive Disorder

Article	Year
Medizinische Monatsschrift fur Pharmazeuten, 2016, Volume: 39, Issue:11 Topics: Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Drug Interactions; Female; Follow-Up Studies; Germany; Humans; Male; Milnacipran; Receptors, Neurotransmitter; Treatment Outcome	2016
Levomilnacipran (Fetzima) a new SNRI for depression. The Medical letter on drugs and therapeutics, 2013, Dec-23, Volume: 55, Issue:1432 Topics: Antidepressive Agents; Cyclopropanes; Depressive Disorder; Drug Approval; Drug Interactions; Humans; Milnacipran; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2013
Influence of painful physical symptoms in the treatment of Japanese patients with melancholic major depressive disorder: A prospective cohort study. Psychiatry research, 2016, Aug-30, Volume: 242 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Comorbidity; Cyclopropanes; Depressive Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Milnacipran; Pain; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome	2016
Psychiatric comorbidities and use of milnacipran in patients with chronic dizziness. Journal of vestibular research : equilibrium & orientation, 2016, 07-02, Volume: 26, Issue:3 Topics: Anxiety Disorders; Chronic Disease; Comorbidity; Cyclopropanes; Depressive Disorder; Dizziness; Female; Fluvoxamine; Humans; Male; Mental Disorders; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2016
Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice. Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:3 Topics: Analysis of Variance; Animals; Antidepressive Agents; Brain; Bupropion; Chromatography, High Pressure Liquid; Cyclopropanes; Depressive Disorder; Desipramine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Male; Mice; Milnacipran; Motor Activity; Paroxetine; Piperidines; Receptors, N-Methyl-D-Aspartate	2017
BNIP-3: a novel candidate for an intrinsic depression-related factor found in NG108-15 cells treated with Hochu-ekki-to, a traditional oriental medicine, or typical antidepressants. Neuroscience research, 2008, Volume: 62, Issue:1 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apoptosis; Brain; Chromatography, High Pressure Liquid; Cyclopropanes; Depressive Disorder; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gene Expression Profiling; Gene Expression Regulation; Hybridomas; Imipramine; Medicine, East Asian Traditional; Membrane Proteins; Mianserin; Mice; Milnacipran; Mitochondrial Proteins; Neurons; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Tumor Cells, Cultured; Up-Regulation	2008
[The use of ixel in the treatment of depression in patients with chronic schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:2 Topics: Adult; Antidepressive Agents; Chronic Disease; Cyclopropanes; Depressive Disorder; Female; Humans; Male; Middle Aged; Milnacipran; Schizophrenia	2009
Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances. Behavioural brain research, 2009, Aug-12, Volume: 201, Issue:2 Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety Disorders; Behavior, Animal; Brain Ischemia; Cyclopropanes; Depressive Disorder; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Fluvoxamine; Hippocampus; Imipramine; Immobility Response, Tonic; Male; Milnacipran; Motor Activity; Rats; Rats, Wistar	2009
[Acute prostatism associated with milnacipran therapy: a case report]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2009,Winter, Volume: 20, Issue:4 Topics: Adult; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Humans; Male; Milnacipran; Prostatic Hyperplasia; Prostatism	2009
Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran. Journal of neurology, neurosurgery, and psychiatry, 2003, Volume: 74, Issue:1 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Female; Gait Disorders, Neurologic; Humans; Milnacipran; Parkinson Disease, Secondary; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Tremor	2003
Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:1 Topics: Adult; Aged; Biomarkers; Cyclopropanes; Depressive Disorder; Female; Homovanillic Acid; Hospitals, University; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Milnacipran; Paroxetine; Patient Selection; Selective Serotonin Reuptake Inhibitors	2004
Efficacy of milnacipran for depressive symptoms in schizophrenia spectrum disorders. Psychiatry and clinical neurosciences, 2004, Volume: 58, Issue:2 Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Cyclopropanes; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Milnacipran; Personality Inventory; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2004
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. The American journal of psychiatry, 2004, Volume: 161, Issue:9 Topics: Adrenergic Uptake Inhibitors; Carrier Proteins; Cyclopropanes; Depressive Disorder; Female; Gene Frequency; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Milnacipran; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Pharmacogenetics; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Symporters; Treatment Outcome	2004
Ejaculation after defecation without orgasm induced by milnacipran. The Journal of neuropsychiatry and clinical neurosciences, 2004,Fall, Volume: 16, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclopropanes; Defecation; Depressive Disorder; Ejaculation; Humans; Male; Milnacipran	2004
Peripheral circulatory disturbance induced by milnacipran. The Journal of neuropsychiatry and clinical neurosciences, 2005,Winter, Volume: 17, Issue:1 Topics: Adult; Cyclopropanes; Depressive Disorder; Humans; Male; Milnacipran; Peripheral Vascular Diseases	2005
Milnacipran for the drastic improvement of refractory pain in a patient without depressive symptoms: a case report. European psychiatry : the journal of the Association of European Psychiatrists, 2005, Volume: 20, Issue:4 Topics: Adrenergic Uptake Inhibitors; Analgesics; Chronic Disease; Cyclopropanes; Depressive Disorder; Dose-Response Relationship, Drug; Femur; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Selective Serotonin Reuptake Inhibitors	2005
The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression. Pharmacology, biochemistry, and behavior, 1999, Volume: 62, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Biogenic Monoamines; Brain Chemistry; Cyclopropanes; Depressive Disorder; Male; Milnacipran; Motor Activity; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Weight Gain	1999
Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study. International clinical psychopharmacology, 2002, Volume: 17, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Case-Control Studies; Cyclopropanes; Depressive Disorder; Female; Fluvoxamine; Humans; Individuality; Male; Milnacipran; Patient Dropouts; Psychiatric Status Rating Scales; Psychomotor Agitation	2002